Order Article Reprints

Kohya R, Suda G, Ohara M, Sasaki T, Yoda T, Sakurai N, Yoshida S, Fu Q, Yang Z, Hosoda S, et al. Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 2023; 15(12):3257. https://doi.org/10.3390/cancers15123257

Kohya, Risako, Goki Suda, Masatsugu Ohara, Takashi Sasaki, Tomoka Yoda, Naofumi Sakurai, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Shunichi Hosoda, and et al. 2023. "Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma" Cancers 15, no. 12: 3257. https://doi.org/10.3390/cancers15123257

Kohya, R., Suda, G., Ohara, M., Sasaki, T., Yoda, T., Sakurai, N., Yoshida, S., Fu, Q., Yang, Z., Hosoda, S., Maehara, O., Ohnishi, S., Tokuchi, Y., Kitagataya, T., Suzuki, K., Kawagishi, N., Nakai, M., Sho, T., Natsuizaka, M., ... Sakamoto, N. (2023). Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma. Cancers, 15(12), 3257. https://doi.org/10.3390/cancers15123257